# Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine

> **NCT01288625** · PHASE4 · WITHDRAWN · sponsor: **Sun Pharmaceutical Industries Limited**

## Conditions studied

- Oral Mucositis
- Stomatitis

## Interventions

- **DRUG:** Amifostine
- **RADIATION:** Amifostine

## Key facts

- **NCT ID:** NCT01288625
- **Lead sponsor:** Sun Pharmaceutical Industries Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** There were IP availability issues due to which the study could not be started.
- **Last updated:** 2021-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01288625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01288625, "Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01288625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*